Menu Search
Equities

Demant A/S

0RGT:LSE

Demant A/S

Actions
  • Price (DKK)256.20
  • Today's Change-1.10 / -0.43%
  • Shares traded12.86k
  • 1 Year change-8.61%
  • Beta--
Data delayed at least 20 minutes, as of Nov 21 2024 15:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Demant A/S, formerly William Demant Holding A/S, is a Denmark-based company engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The Company operates globally, through more than 90 subsidiaries and associates worldwide.

  • Revenue in DKK (TTM)22.38bn
  • Net income in DKK2.65bn
  • Incorporated1983
  • Employees21.50k
  • Location
    Demant A/SKongebakken 9SMOERUM 2765DenmarkDNK
  • Phone+45 39177300
  • Fax+45 39277900
  • Websitehttps://www.demant.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		DEMANT:CPH since
announced		Transaction
value
Dansk HoreCenter A/SDeal completed20 Aug 202420 Aug 2024Deal completed-6.05%14.86m
Data delayed at least 15 minutes, as of Nov 21 2024 15:59 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.